A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
Clinical trial NCT07135219 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07135219
- Sponsor
- Peking University First Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-16
- Primary completion
- 2025-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.